BRAND NAME:
Daxila

GENERIC NAME:
 Dexlansoprazole

THERAPEUTIC SEGMENT:
Anti-Ulcerant

INDICATIONS:
DAXILA is a proton pump inhibitor (PPI) indicated for;
Healing of all grades of erosive esophagitis (EE).
Maintaining healing of EE and relief of heartburn.
Treating heartburn associated with symptomatic non-erosive gastroesophageal reflux disease (GERD).

BRIEF DESCRIPTION:
DAXILA (dexlansoprazole) is delayed-release capsules, a proton pump inhibitor, exhibiting high efficacy in the treatment of symptoms and lesions associated with erosive oesophagitis caused by gastroesophageal reflux disease (GERD). The key to DAXILA’s two releases of medicine is its Dual Delayed Release technology, which combines two different types of granules in one pill. So DAXILA begins to deliver the first release of medicine within an hour of taking your pill. Then, around 4-5 hours later, a second release of medicine arrives.

DOSAGE FORM:
30 mg & 60 mg Delayed Release Capsule

PACK SIZE:
Capsules: 30’s